Cummins, L <br/><br/>
Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.  [electronic resource] 

 -  Internal medicine journal  Dec 2015 
 - 1266-73 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1445-5994 
<br/><br/><label>Standard No.: </label>10.1111/imj.12896  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Rheumatoid--drug therapy<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Hydroxychloroquine--administration & dosage<br/>Immunosuppressive Agents--administration & dosage<br/>Isoxazoles--administration & dosage<br/>Leflunomide<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Prospective Studies<br/>Remission Induction<br/>Sulfasalazine--administration & dosage<br/>Treatment Outcome<br/>United States--epidemiology